PASS Risk Calculators

"Short-Term" Biopsy Risk Calculator

This PASS Risk Calculator provides an estimate for how likely a man is to have more aggressive cancer on his next prostate biopsy. The calculator characterizes the risk of a pathological Gleason upgrading event for men who have already been diagnosed with prostate cancer and are undergoing active surveillance. It is not intended to provide a risk estimate for new diagnosis of prostate cancer.  The provided estimate may help decide whether a biopsy is necessary at this time.

 

 

"Long-Term" Risk Calculator

... in production

This PASS Risk Calculator will provide an estimate for how likely a man is to have more aggressive cancer found in a biopsy within 5 years. The calculator characterizes the risk of a pathological Gleason upgrading event for men who have already been diagnosed with prostate cancer and are undergoing active surveillance.

 

 


Previous Calculators

Canary-EDRN Active Surveillance Biopsy Risk Calculator (version 1.0)
This calculator was used to predict the risk of whether or not the next follow-up prostate biopsy would have an increase in Gleason score or an increase in percentage of cores positive for cancer.